The gap between trailing and forward multiples is extreme, reflecting the market's belief that the 2025 losses were transitory and that the Profit Recovery Plan will restore historical profitability. However, the 2026Q4 operating margin of -9.2% and net margin of -3.2%, as reported in financial statements, suggest that the recovery is uneven and may be priced too optimistically. Investors should compare EL's forward EV/EBITDA of 18.2x to L'Oréal's typical 20x+ to assess whether the discount is warranted given EL's higher operational risk and China exposure.

The 800 basis point gross margin improvement suggests successful premium pricing and mix shifts, but the operating margin collapse points to SG&A overhang and restructuring costs that have not yet been fully absorbed. Net margin of -3.2% in 2026Q4, as reported in financial statements, reflects non-operating items and impairments that continue to distort quarterly earnings. The true earning power will only be visible once operating leverage returns consistently, which the prior quarters' swings from -14.5% to 13.9% indicate is not yet stable.

The ten-quarter ROIC trend shows a company that was generating modest positive returns in 2024, then plunged into negative territory during the 2025 destocking, and is now attempting to recover. The 2026Q4 ROIC of -2.7% versus the 2024Q3 3.1% indicates that the capital base has not yet been restructured enough to generate consistent returns above the cost of capital. The driver is not margin alone but also asset efficiency, as asset turnover has remained stagnant around 0.17-0.22, suggesting that inventory and receivables are still elevated relative to sales.

The 50-day improvement in CCC is encouraging, but the 258-day DIO in 2026Q4 is abnormally high, even for a prestige beauty company, and suggests that destocking efforts are incomplete or that seasonal inventory builds are occurring. DSO has remained stable around 41 days, while DPO has increased to 191 days, indicating that EL is stretching supplier payments to manage cash flow, which may not be sustainable. The working capital swings, as seen in the prior cash flow analysis, highlight that inventory and receivables volatility continues to drive cash flow unpredictability.

The reduction in D/E from 2.74 to 2.19 is positive, but the absolute level remains high, especially given that equity has contracted to $3.8B due to cumulative losses. The negative interest coverage in 2026Q4, as reported in financial statements, is a red flag, though it may be driven by one-time charges; the 2026Q3 coverage of 3.18x shows that the company can cover interest when operations normalize. The prior balance sheet analysis noted that the reported D/E excludes operating lease liabilities, which are material for retail-heavy operations, so true leverage may be higher than reported.

The quick ratio below 1.0 suggests that if inventory becomes difficult to liquidate, EL may face short-term cash pressure, especially given the high DIO of 258 days. Cash of $3.5B provides a buffer, but the negative operating cash flow in 2026Q1 and the volatile FCF margins indicate that liquidity can tighten quickly. The current ratio of 1.22 is below the 1.58 seen in 2024Q3, showing a gradual erosion of the liquidity cushion as the company has used cash to pay down debt.